Gynecologic Cancers

Latest News

The use of ChatGPT may help to improve genetic counseling for patients with gynecologic cancer.
AI May Improve Genetic Counseling Recommendations for Gynecologic Cancers

March 18th 2024

The use of ChatGPT may help to improve genetic counseling for patients with gynecologic cancer.

Treatment with simple hysterectomy reduces the incidence of urinary incontinence compared with radical hysterectomy in patients with low-risk cervical cancer.
Simple Hysterectomy Noninferior Vs Radical Hysterectomy in Cervical Cancer

March 11th 2024

Data from the phase 3 RUBY trial support the recommendation for dostarlimab plus chemotherapy for patients with advanced MSI-H/dMMR endometrial cancer.
NICE Recommends Dostarlimab/Chemo for MSI-H/dMMR Endometrial Cancer

March 5th 2024

FDA Grants Priority Review to Pembrolizumab/Chemo in Endometrial Cancer | Image Credit: © freshidea - stock.adobe.com.
FDA Grants Priority Review to Pembrolizumab/Chemo in Endometrial Cancer

February 20th 2024

Tisotumab vedotin may become the first antibody drug conjugate to receive marketing authorization in the European Union as a treatment for those with cervical cancer.
EMA Validates Tisotumab Vedotin Marketing Application in Cervical Cancer

February 5th 2024

Video Series
Video Interviews
Podcasts
The FDA approval of pembrolizumab plus chemoradiation benefits patients with stage III to IVA cervical cancer based on findings from the KEYNOTE-A18 trial, according to Jyoti S. Mayadev, MD.
Pharmaceutical, gynecologic oncology, and physician perspectives shed light on potentially mitigating the ongoing carboplatin and cisplatin shortages’ effects on cancer care in the United States.
Experts from University of California, Los Angeles Health and Mayo Clinic discuss key data presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in the gynecologic and gastrointestinal cancer spaces and how they may impact patient care.
Experts from UCLA Health discuss key data presented at The Society of Gynecologic Oncology 2023 Annual Meeting on Women’s Cancer and how they may apply to clinical practice.

More News